Alemtuzumab-induced thyroid disease: observational data from an Italian cohort of patients

被引：0

作者：

Moiola, L. ^{[1
]}

Nozzolillo, A. ^{[2
]}

Frau, J. ^{[3
]}

Cocco, E. ^{[4
]}

Manzoni, M. ^{[5
]}

Di Filippo, L. ^{[5
]}

Lanzillo, R. ^{[6
]}

Bresciamorra, V. ^{[6
]}

Valerio, C. ^{[6
]}

Pia, A. ^{[7
]}

Capobianco, M. ^{[8
,9
]}

Malucchi, S. ^{[8
,9
]}

Bertolotto, A. ^{[8
,9
]}

Rinaldi, F. ^{[10
]}

Margoni, M. ^{[11
]}

Zaffaroni, M. ^{[12
]}

Lapucci, C. ^{[13
]}

Inglese, M. ^{[13
]}

Mirabella, M. ^{[14
]}

Bianco, M. A. ^{[14
]}

Patti, F. ^{[15
]}

Chisari, C. ^{[15
]}

Cavalla, P. ^{[16
]}

Vercellino, M. ^{[16
]}

Zanetta, C. ^{[17
]}

Comi, G. ^{[1
]}

Filippi, M. ^{[1
]}

机构：

[1] Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Dept Neurol, Multiple Sclerosis Ctr, Milan, Italy

[2] Univ Naples Federico II, Multiple Sclerosis Clin Care & Res Ctr, Dept Neurosci Reprod Sci & Odontostomatol, Naples, Italy

[3] Univ Cagliari, ATS, Multiple Sclerosis Ctr, Cagliari, Italy

[4] Univ Cagliari, Cagliari, Italy

[5] IRCCS San Raffaele Hosp, Endocrine & Metab Disorders Unit, Milan, Italy

[6] Univ Naples Federico II, Neurosci Reprod & Odontostomatol Sci Dept, Naples, Italy

[7] Univ Hosp San Luigi Gonzaga, SS Endocrinol, Biol & Sci Dept, Orbassano, Italy

[8] Univ Hosp San Luigi Gonzaga, Dept Neurol, Orbassano, Italy

[9] Univ Hosp San Luigi Gonzaga, Reg Referral Multiple Sclerosis Ctr, Orbassano, Italy

[10] Univ Padua, Univ Hosp, Multiple Sclerosis Ctr Veneto Reg, Dept Neurosci, Padua, Italy

[11] Univ Padua, Univ Hosp, Dept Neurosci DNS, Padua, Italy

[12] Hosp Gallarate, ASST Valle Olona, Multiple Sclerosis Ctr, Gallarate, Italy

[13] Univ Genua, Dept Neurosci Rehabil Ophthalmol Genet Maternal &, Genoa, Italy

[14] Univ Cattolica Sacro Cuore, Fdn Policlin A Gemelli IRCSS, Rome, Italy

[15] Univ Catania, Dept GF Ingrassia Med & Surg Sci & Adv Technol, Neurosci Sect, Catania, Italy

[16] Univ Hosp Turin, MS Ctr, Dept Neurosci & Mental Hlth, Turin, Italy

[17] Univ Vita Salute San Raffaele, San Raffaele Sci Inst, Dept Neurol, Multiple Sclerosis, Milan, Italy

来源：

MULTIPLE SCLEROSIS JOURNAL | 2019年 / 25卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

EP1584

引用

页码：879 / 880

页数：2

共 50 条

[41] Ocular Findings in Alemtuzumab (Campath-1H)-induced Thyroid Eye Disease
Tanya Trinh
Haridas, Anjana S.
Sullivan, Timothy J.
OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2016, 32 (06): : E128 - E129
[42] Work productivity is associated with disease activity and functional ability in Italian patients with early axial spondyloarthritis: an observational study from the SPACE cohort
de Hooge, Manouk
Ramonda, Roberta
Lorenzin, Mariagrazia
Frallonardo, Paola
Punzi, Leonardo
Ortolan, Augusta
Doria, Andrea
ARTHRITIS RESEARCH & THERAPY, 2016, 18
[43] SERRATED POLYPOSIS: ENDOSCOPIC, PATHOLOGICAL AND CLINICAL DATA FROM A COHORT OF ITALIAN PATIENTS
Moneghini, D.
Missale, G.
Nascimbeni, R.
Villanacci, V.
Minelli, L.
Cengia, G.
Cestari, R.
DIGESTIVE AND LIVER DISEASE, 2014, 46 : S97 - S97
[44] A real life, multicenter, observational study to evaluate safety and efficacy of the switch from alemtuzumab to ocrelizumab in MS patient with evidence of disease activity after two alemtuzumab courses: the italian experience
Lapucci, Caterina
Frau, Jessica
Cocco, Eleonora
Coghe, Giancarlo
Petracca, Maria
Lanzillo, Roberta
Vercellino, Marco
Cavalla, Paola
Bianco, Assunta
Mirabella, Massimiliano
Di Mauro, Giovanni
Landi, Doriana
Marfia, Girolama Alessandra
Clerici, Valentina Torri
Roldan, Eugenia Tomas
Ferro, Maria Teresa
Grossi, Paola
Zaffaroni, Mauro
Ronzoni, Marco
Nozzolillo, Agostino
Moiola, Lucia
Pinardi, Federica
Novi, GIovanni
Cellerino, Maria
Antonio, Ucccelli
Inglese, Matilde
MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 441 - 442
[45] PRESENCE OF THYROID DISEASE IN RHEUMATOID ARTHRITIS PATIENTS IS PREDICTOR OF WORSE INITIAL TREATMENT RESPONSE: AN OBSERVATIONAL, COHORT STUDY
Emamifar, A.
Larsen, R. Hviid
Andreasen, R. Asmussen
Hansen, I. M. Jensen
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 533 - 533
[46] Short-term evaluation of alemtuzumab to ocrelizumab switch in ms patients with disease activity after alemtuzumab: an italian multicentric study
Lapucci, C.
Frau, J.
Cocco, E.
Cavalla, P.
Vercellino, M.
Petracca, M.
Lanzillo, R.
Grossi, P.
Ferro, M. T.
Guaschino, C.
Zaffaroni, M.
Tazza, F.
Novi, G.
Uccelli, A.
Inglese, M.
MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 195 - 196
[47] Short-term evaluation of alemtuzumab to ocrelizumab switch in MS patients with disease activity after alemtuzumab: an Italian multicentric study
Lapucci, Caterina
Frau, Jessica
Cocco, Eleonora
Vercellino, Marco
Cavalla, Paola
Petracca, Maria
Lanzillo, Roberta
Grossi, Paola
Ferro, Maria Teresa
Zaffaroni, Mauro
Tazza, Francesco
Novi, Giovanni
Uccelli, Antonio
Inglese, Matilde
NEUROLOGY, 2021, 96 (15)
[48] Alemtuzumab as rescue therapy in a cohort of 50 relapsing-remitting MS patients with breakthrough disease on fingolimod: a multi-center observational study
Huhn, Konstantin
Bayas, Antonios
Doerck, Sebastian
Frank, Benedikt
Gerbershagen, Kathrin
Hellwig, Kerstin
Kallmann, Boris
Kleinschnitz, Christoph
Kleiter, Ingo
Lee, De-Hyung
Limmroth, Volker
Maeurer, Mathias
Meuth, Sven
Rieckmann, Peter
Ruck, Tobias
Gold, Ralf
Linker, Ralf A.
JOURNAL OF NEUROLOGY, 2018, 265 (07) : 1521 - 1527
[49] The prevention of alemtuzumab-induced cytomegalovirus reactivation: still a matter of debate. An update from Pesaro experience with once weekly intravenous ganciclovir
Isidori, Alessandro
Visani, Giuseppe
LEUKEMIA & LYMPHOMA, 2009, 50 (02) : 294 - 296
[50] Italian multicenter observational study on real-life experience with alemtuzumab in naive patients with aggressive multiple sclerosis
Moiola, Lucia
Zanetta, Chiara
Di Cristinzi, Maria
Nozzolillo, Agostino
Rinaldi, Francesca
Brambilla, Laura
Annovazzi, Pietro
Lus, Giacomo
Puorro, Giorgia
Frau, Jessica
Malucchi, Simona
Bianco, Assunta
Lapucci, Caterina
Marfia, Girolama
Gallo, Antonio
Cerqua, Raffaella
Cavalla, Paola
Filippi, Massimo
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2021, 429

← 1 2 3 4 5 →